Applied Clinical Trials-01-01-2008

EMEA and EC admit to legislation difficulties, and many voice their ideas in an effort to make improvements.

No longer a futuristic concept, adaptive clinical trials have become a reality that must be considered.

FDA and sponsors implement FDAAA as pressure builds to curb drug prices and tweak the R&D process.

TrialStat's EDC Platform Adds Graphical Reporting Features and More

Steady enrollment and optimal trial metrics can become reality with the right processes and tools.

Lack of minority clinical investigators behind dearth of minority subjects in trials.

Both parties benefit from intentional friendships, and nowadays CRAs are key to this cordial effort.

Recent announcements streamline adverse event reporting

Saul Shiffman, cofounder and chief scientific officer of invivodata, Inc., examines how patient-reported data collection has been transformed since 1987.